Company intelligence / Profile preview
Cytobiologics
Rangareddy/Hyderabad*, Telangana, Indiacytobiologics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cytobiologics is an active multinational healthcare company specializing in the development and manufacturing of plasma-derived therapies and medical devices. It serves as the sole marketing business for Promea Therapeutics’ Plasma Derivatives Manufacturing Unit (PDMU), with a mission to improve global health through innovative life science solutions. The company has demonstrated significant financial growth since its founding in India in 2021.
- Modalities
- Plasma-derived therapiesMedical devices
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Promea Therapeutics
Beyond the preview
Go deeper on Cytobiologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytobiologics.